Quinolone antibacterials. An update of their pharmacology and therapeutic use.
about
Antimicrobial safety: focus on fluoroquinolonesTreatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.In vitro activities of new quinolones against Helicobacter pylori.Characterization of DNA topoisomerase activity in two strains of Mycoplasma fermentans and in Mycoplasma pirum.Is repositioning of drugs a viable alternative in the treatment of tuberculosis?Influence of renal failure on ciprofloxacin pharmacokinetics in rats.Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections.Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesInterplay of the Quality of Ciprofloxacin and Antibiotic Resistance in Developing Countries.Synthesis and characterization of N-Mannich based prodrugs of ciprofloxacin and norfloxacin: In vitro anthelmintic and cytotoxic evaluation.Partial Achilles tendon ruptures associated with fluoroquinolone antibiotics: a case report and literature review.Sparfloxacin-associated corneal epithelial toxicity.Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.Bioequivalence evaluation of norfloxacin 400 mg tablets (Uroxin and Noroxin) in healthy human volunteers.Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections.Rapid Chemiluminescent Determination of Enrofloxacin in Eggs and Veterinary Drugs
P2860
Q28255152-C7AFE338-AD03-4966-A560-D0269BC112CEQ33696350-E6966FD0-BF47-4CF1-A7E2-A8DAB778E7E9Q35136607-ED3E66E5-6CBA-4B25-9903-F502B9A7E1C8Q35139561-56993F24-B834-4BB5-B320-7F696B45E5BEQ35631689-D3A958C1-11DE-47D2-85CA-2073A2C6EF56Q38053000-E9470207-4D5D-4BD0-8A89-81C5AA0589C5Q39556635-C304601F-9DE0-4673-B33B-A12BAF41B52BQ39783862-1B44ECD9-44C1-4829-8887-2643866F7A10Q39784609-98EF6820-0978-4A05-900A-3FA5DE6CA666Q39785094-FDF68949-5D6C-4FD4-B7FC-48014E8E64F5Q40067159-A2C3C0C8-E7B5-419B-917A-525A184415BEQ40999602-47CFDD7D-5611-4490-A600-1D3365ED5CC9Q41156734-B2602912-6872-4813-81E6-2918FD196F96Q41732288-49C34996-A705-4F36-A383-C7CC6D716AFFQ42991857-617767AE-5EDE-477A-8697-4728838EEDE1Q51551223-FB4B31F9-19A7-4B79-B222-8BED98CE6560Q54296506-799FA4DA-9D17-40CF-8DB0-4F4C21BE27AEQ58129674-4051A13D-CCA0-4BF8-9B9C-BB8CD2E8318E
P2860
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1994
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
@en
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
@nl
type
label
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
@en
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
@nl
prefLabel
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
@en
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
@nl
P1433
P1476
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
@en
P2093
von Rosenstiel N
P304
P356
10.2165/00003495-199447060-00003
P577
1994-06-01T00:00:00Z
P6179
1006772446